Finance

Lists
600267:SHA
Zhejiang Hisun Pharmaceutical Co., Ltd.
10,96 CNY
-1,88%
(-0,21) 1D
16 ოქტ, 15:00:01 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600267...
Open
11,24 CNY
High
11,50 CNY
Low
10,84 CNY
Mkt. cap
12,94 მლრდ.
Avg. vol.
20,43 მლნ.
Volume
27,90 მლნ.
Dividend
1,92%
Quarterly dividend
0,05 CNY
Ex-dividend date
16 ივნ. 2026
P/E ratio
14,52
52-wk high
15,00 CNY
52-wk low
9,35 CNY
EPS
0,75 CNY
Shares outstanding
965,53 მლნ.
No. of employees
9 ათ.
Open
11,24 CNY
High
11,50 CNY
Low
10,84 CNY
Mkt. cap
12,94 მლრდ.
Avg. vol.
20,43 მლნ.
Volume
27,90 მლნ.
Dividend
1,92%
Quarterly dividend
0,05 CNY
Ex-dividend date
16 ივნ. 2026
P/E ratio
14,52
52-wk high
15,00 CNY
52-wk low
9,35 CNY
EPS
0,75 CNY
Shares outstanding
965,53 მლნ.
No. of employees
9 ათ.
News stories
From web sources and news partners
About Zhejiang Hisun Pharmaceutical Co., Ltd.
CEO-
Employees8,75 ათ.
Founded1956
Headquarters-
SectorPharmaceutical industry
Websitehisunpharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
2,67 მლრდ.
2,63 მლრდ.
2,39 მლრდ.
2,09 მლრდ.
Cost of goods sold
1,37 მლრდ.
1,58 მლრდ.
1,17 მლრდ.
873,36 მლნ.
Cost of revenue
1,37 მლრდ.
1,58 მლრდ.
1,17 მლრდ.
873,36 მლნ.
Research and development expenses
169,79 მლნ.
106,39 მლნ.
134,44 მლნ.
133,58 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
767,80 მლნ.
723,79 მლნ.
706,45 მლნ.
704,72 მლნ.
Operating expense
924,27 მლნ.
897,41 მლნ.
845,10 მლნ.
888,74 მლნ.
Total operating expenses
2,29 მლრდ.
2,48 მლრდ.
2,02 მლრდ.
1,76 მლრდ.
Operating income
382,05 მლნ.
149,99 მლნ.
370,87 მლნ.
322,92 მლნ.
Other non operating income
-22,42 მლნ.
21,53 მლნ.
-3,69 მლნ.
2,98 მლნ.
EBT including unusual items
215,43 მლნ.
195,64 მლნ.
482,46 მლნ.
341,12 მლნ.
EBT excluding unusual items
337,55 მლნ.
149,16 მლნ.
529,80 მლნ.
308,48 მლნ.
Income tax expense
52,29 მლნ.
116,21 მლნ.
123,91 მლნ.
57,95 მლნ.
Effective tax rate
24,27%
59,40%
25,68%
16,99%
Other operating expenses
-14,72 მლნ.
61,27 მლნ.
12,09 მლნ.
27,00 მლნ.
Net income
161,86 მლნ.
79,78 მლნ.
355,69 მლნ.
280,78 მლნ.
Net profit margin
6,06%
3,04%
14,88%
13,47%
Earnings per share
-
-
-
-
Interest and investment income
2,80 მლნ.
3,79 მლნ.
179,34 მლნ.
2,40 მლნ.
Interest expense
-23,75 მლნ.
-21,61 მლნ.
-16,72 მლნ.
-11,96 მლნ.
Net interest expenses
-20,95 მლნ.
-17,82 მლნ.
162,62 მლნ.
-9,56 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
648,89 მლნ.
388,47 მლნ.
609,35 მლნ.
551,54 მლნ.
Gain or loss from assets sale
305,01 ათ.
-5,23 მლნ.
-
-849,83 ათ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები